Your browser doesn't support javascript.
loading
Pharmacological Interventions for Primary Psychodermatologic Disorders: An Evidence Mapping and Appraisal of Randomized Controlled Trials.
Turk, Tarek; Liu, Chaocheng; Fujiwara, Esther; Straube, Sebastian; Hagtvedt, Reidar; Dennett, Liz; Abba-Aji, Adam; Dytoc, Marlene.
Afiliación
  • Turk T; 3158 Department of Psychiatry, University of Alberta, Edmonton, Canada.
  • Liu C; Department of Dermatology and Venereology, Syrian Arab Red Crescent Hospital, Ministry of Health, Damascus, Syria.
  • Fujiwara E; 8166 Department of Dermatology and Skin Science, University of British Columbia, Vancouver, Canada.
  • Straube S; 3158 Department of Psychiatry, University of Alberta, Edmonton, Canada.
  • Hagtvedt R; 12357 Division of Preventive Medicine, Department of Medicine, University of Alberta, Edmonton, Canada.
  • Dennett L; 12357 ABA, Alberta School of Business, University of Alberta, Edmonton, Canada.
  • Abba-Aji A; 67111 Scott Health Sciences Library, University of Alberta, Edmonton, Canada.
  • Dytoc M; 3158 Department of Psychiatry, University of Alberta, Edmonton, Canada.
J Cutan Med Surg ; 27(2): 140-149, 2023.
Article en En | MEDLINE | ID: mdl-36802832
BACKGROUND: The lack of clinical guidelines for the treatment of primary psychodermatologic disorders (PPDs) hinders the delivery of optimal care to patients. The review aimed to identify, appraise, and summarize the currently available evidence about the safety and effectiveness of pharmacological management of PPDs through randomized controlled trials (RCTs). METHODS: The Preferred Reporting Items for Systematic Review and Meta-Analyses (PRIMSA) statement and the Global Evidence Mapping Initiative guidance were followed. Medline, Embase, PsycInfo, Cochrane and Scopus were searched, and two reviewers independently completed article review, data extraction, and quality assessment. RESULTS: Among 2618 unique studies, full texts of 83 were reviewed and 21 RCTs were included. Five PDDs were identified: trichotillomania (n = 12), pathologic skin picking (n = 5), nail biting (n = 2), delusional parasitosis (n = 1), and dermatitis from compulsive hand washing (n = 1). Seven different classes of medications were investigated: SSRIs (i.e., fluoxetine, sertraline, and citalopram), tricyclic antidepressants (i.e., clomipramine and desipramine), antipsychotics (i.e., olanzapine and pimozide), anticonvulsant (i.e., lamotrigine), N-acetylcysteine, inositol, and milk thistle. RCT-derived evidence supports the use of antidepressants in trichotillomania (sertraline and clomipramine), pathologic skin picking (fluoxetine), pathologic nail biting and dermatitis from compulsive hand washing (clomipramine or desipramine); antipsychotics in trichotillomania (olanzapine) and delusional parasitosis (pimozide); N-acetyl cysteine in trichotillomania and skin picking. CONCLUSION: Few pharmacotherapies for primary psychodermatologic disorders are assessed through controlled trials in the literature. This review serves as a roadmap for researchers and clinicians to reach informed decisions with current evidence, and to build on it to establish guidelines in the future.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antipsicóticos / Dermatitis Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: J Cutan Med Surg Asunto de la revista: DERMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Antipsicóticos / Dermatitis Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: J Cutan Med Surg Asunto de la revista: DERMATOLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Canadá